» Articles » PMID: 21945520

Mitochondrial Adenine Nucleotide Transport and Cardioprotection

Overview
Date 2011 Sep 28
PMID 21945520
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondria are highly metabolically active cell organelles that not only act as the powerhouse of the cell by supplying energy through ATP production, but also play a destructive role by initiating cell death pathways. Growing evidence recognizes that mitochondrial dysfunction is one of the major causes of cardiovascular disease. Under de-energized conditions, slowing of adenine nucleotide transport in and out of the mitochondria significantly attenuates myocardial ischemia-reperfusion injury. The purpose of this review is to elaborate on and update the mechanistic pathways which may explain how altered adenine nucleotide transport can influence cardiovascular function. This article is part of a Special Issue entitled "Local Signaling in Myocytes".

Citing Articles

Isoquercitrin alleviates pirarubicin-induced cardiotoxicity and by inhibiting apoptosis through Phlpp1/AKT/Bcl-2 signaling pathway.

Wang L, Ma J, Chen C, Lin B, Xie S, Yang W Front Pharmacol. 2024; 15:1315001.

PMID: 38562460 PMC: 10982373. DOI: 10.3389/fphar.2024.1315001.


Ginsenoside F1 attenuates pirarubicin-induced cardiotoxicity by modulating Nrf2 and AKT/Bcl-2 signaling pathways.

Zhang Y, Ma J, Liu S, Chen C, Li Q, Qin M J Ginseng Res. 2023; 47(1):106-116.

PMID: 36644383 PMC: 9834006. DOI: 10.1016/j.jgr.2022.06.002.


Nuclear-mitochondrial communication involving miR-181c plays an important role in cardiac dysfunction during obesity.

Roman B, Kaur P, Ashok D, Kohr M, Biswas R, ORourke B J Mol Cell Cardiol. 2020; 144:87-96.

PMID: 32442661 PMC: 7483371. DOI: 10.1016/j.yjmcc.2020.05.009.


Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin.

Ren L, Li Q, Zhang Y Biomed Res Int. 2020; 2020:9396512.

PMID: 32149146 PMC: 7057019. DOI: 10.1155/2020/9396512.


Xeroderma Pigmentosum Group D (XPD) Inhibits the Proliferation Cycle of Vascular Smooth Muscle Cell (VSMC) by Activating Glycogen Synthase Kinase 3β (GSK3β).

Li Q, Liao C, Xu W, Li G, Hong K, Cheng X Med Sci Monit. 2018; 24:5951-5959.

PMID: 30146633 PMC: 6122044. DOI: 10.12659/MSM.909614.


References
1.
Schleiff E, Soll J . Membrane protein insertion: mixing eukaryotic and prokaryotic concepts. EMBO Rep. 2005; 6(11):1023-7. PMC: 1371041. DOI: 10.1038/sj.embor.7400563. View

2.
Zorov D, Juhaszova M, Yaniv Y, Nuss H, Wang S, Sollott S . Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovasc Res. 2009; 83(2):213-25. PMC: 2701724. DOI: 10.1093/cvr/cvp151. View

3.
Ruiz-Meana M, Garcia-Dorado D, Miro-Casas E, Abellan A, Soler-Soler J . Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion. Cardiovasc Res. 2006; 71(4):715-24. DOI: 10.1016/j.cardiores.2006.06.019. View

4.
Baines C, Song C, Zheng Y, Wang G, Zhang J, Wang O . Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res. 2003; 92(8):873-80. PMC: 3691672. DOI: 10.1161/01.RES.0000069215.36389.8D. View

5.
Nishihara M, Miura T, Miki T, Sakamoto J, Tanno M, Kobayashi H . Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol. 2006; 291(2):H748-55. DOI: 10.1152/ajpheart.00837.2005. View